Platelet-rich plasma and macular hole surgery: A clue to their mode of action and the influence of anti-platelet agents.
Francesco Maria D'AlterioMariantonia FerraraAlan BagnallKate L TalksRoxane Jo HillierPublished in: European journal of ophthalmology (2022)
Appropriate management of anti-platelet therapy may be relevant when planning aPRP use, though further large-scale studies are needed to assess the precise effect of anti-platelet therapy on the efficacy of aPRP, and to confirm the potential role of aPRP in patients with Alport syndrome.